COVID-19 Information for Pharmacy

Evaluating COVID-19 status

COVID Respiratory Medications (Nebulization vs. Inhaler) Update

COVID-19 Hotline for Pharmacists

COVID-19 stewardship folder

HH COVID-19 information folder

Custom Applications (to sign up for vaccination)

Employee Exposure Info

Remdesivir Emergency Use Authorization Info (Order Verification Process):

- Remdesivir Criteria for Use

- Remdesivir health care provider fact sheet

- Remdesivir patient fact sheet (for Pediatrics): English version, Spanish version

IL-6 COVID-19 inclusion/exclusion criteria, dosage, and administration guide

8/20/21 je Sarilumab a Tocilizumab Alternative (ADULTS ONLY)

Baricitinib Criteria For Use

- Baricitinib patient fact sheet: English version, Spanish version

Dexamethasone Criteria for Use

Monoclonal Antibody Combination Inpatient Order Process

Casirivimab/Imdevimab (REGEN-COV) Emergency Use Authorization Info:

- Casirivimab/Imdevimab Criteria for Use

- Casirivimab/Imdevimab healthcare provider fact sheet

- Casirivimab/Imdevimab EUA Letter of Authorization

- Casirivimab/Imdevimab FAQ on EUA

- Casirivimab/Imdevimab patient fact sheet: English version, Spanish version

Bamlanivimab/Etesevimab Criteria for Use

- Bamlanivimab/Etesevimab patient fact sheet: English version, Spanish version

Sotrovimab Emergency Use Authorization Info:

- Sotrovimab Criteria for Use (providers are responsible for screening patients)

- Sotrovimab healthcare provider fact sheet

- Sotrovimab EUA Letter of Authorization

- Sotrovimab patient fact sheet: English version, Spanish version

Code Blue Update for Phamacists